Lassa mammarenavirus

Source: Wikipedia, the free encyclopedia.
(Redirected from
Lassa virus
)
Lassa mammarenavirus
TEM micrograph of "Lassa mammarenavirus" virions
virions
Virus classification Edit this classification
(unranked): Virus
Realm: Riboviria
Kingdom: Orthornavirae
Phylum:
Negarnaviricota
Class: Ellioviricetes
Order: Bunyavirales
Family: Arenaviridae
Genus: Mammarenavirus
Species:
Lassa mammarenavirus
Synonyms
  • Lassa virus

Lassa mammarenavirus (LASV) is an

Lassa hemorrhagic fever,[1]
a type of
Republic of Guinea, Nigeria, and Liberia, where the annual incidence of infection is between 300,000 and 500,000 cases, resulting in 5,000 deaths per year.[2]

As of 2012 discoveries within the

savannah ecozone in west Africa.[3] There are no approved vaccines against Lassa fever for use in humans.[4]

Discovery

In 1969, missionary nurse Laura Wine fell ill with a mysterious disease she contracted from an obstetrical patient in Lassa, a village in

Mastomys natalensis, was found to be the main reservoir of the virus in West Africa, able to shed virus in its urine and feces without exhibiting visible symptoms.[11][12]

Virology

Structure and genome

Lassa virus structure and genome.Figure by Fehling et al., 2012[13]

Lassa viruses[14][15] are enveloped, single-stranded, bisegmented, ambisense RNA viruses. Their genome[16] is contained in two RNA segments that code for two proteins each, one in each sense, for a total of four viral proteins.[17] The large segment encodes a small zinc finger protein (Z) that regulates transcription and replication,[18][19] and the RNA polymerase (L). The small segment encodes the nucleoprotein (NP) and the surface glycoprotein precursor (GP, also known as the viral spike), which is proteolytically cleaved into the envelope glycoproteins GP1 and GP2 that bind to the alpha-dystroglycan receptor and mediate host cell entry.[20]

Lassa fever causes hemorrhagic fever frequently shown by immunosuppression. Lassa mammarenavirus replicates very rapidly, and demonstrates temporal control in replication.[21] The first replication step is transcription of mRNA copies of the negative- or minus-sense genome. This ensures an adequate supply of viral proteins for subsequent steps of replication, as the NP and L proteins are translated from the mRNA. The positive- or plus-sense genome, then makes viral complementary RNA (vcRNA) copies of itself. The RNA copies are a template for producing negative-sense progeny, but mRNA is also synthesized from it. The mRNA synthesized from vcRNA are translated to make the GP and Z proteins. This temporal control allows the spike proteins to be produced last, and therefore, delay recognition by the host immune system.[citation needed]

Nucleotide studies of the genome have shown that Lassa has four lineages: three found in Nigeria and the fourth in Guinea, Liberia, and Sierra Leone. The Nigerian strains seem likely to have been ancestral to the others but additional work is required to confirm this.[22]

Receptors

Entry mechanisms of Old World and New World arenaviruses.

Lassa mammarenavirus gains entry into the host cell by means of the cell-surface receptor the

Junin, and Sabia in addition to the non pathogenic Amapari virus, use the transferrin receptor 1. A small aliphatic amino acid at the GP1 glycoprotein amino acid position 260 is required for high-affinity binding to alpha-DG. In addition, GP1 amino acid position 259 also appears to be important, since all arenaviruses showing high-affinity alpha-DG binding possess a bulky aromatic amino acid (tyrosine or phenylalanine) at this position.[citation needed
]

Unlike most enveloped viruses which use clathrin coated pits for cellular entry and bind to their receptors in a pH dependent fashion, Lassa and lymphocytic choriomeningitis virus instead use an endocytotic pathway independent of clathrin, caveolin, dynamin and actin. Once within the cell the viruses are rapidly delivered to endosomes via vesicular trafficking albeit one that is largely independent of the small GTPases Rab5 and Rab7. On contact with the endosome pH-dependent membrane fusion occurs mediated by the envelope glycoprotein, which at the lower pH of the endosome binds the lysosome protein LAMP1 which results in membrane fusion and escape from the endosome.[citation needed]

Life cycle

Lassa virus life cycle. Figure by Fehling et al., 2012[13]

The life cycle of Lassa mammarenavirus is similar to the Old World arenaviruses. Lassa mammarenavirus enters the cell by the

virion envelope when the virus buds and release from the cell membrane.[25]

Pathogenesis

Scanning electron micrograph
of Lassa virus (in orange) budding off an infected cell

Lassa fever is caused by the Lassa mammarenavirus. The symptoms include flu-like illness characterized by fever, general weakness, cough, sore throat, headache, and gastrointestinal manifestations. Hemorrhagic manifestations include vascular permeability.[4]

Upon entry, the Lassa mammarenavirus infects almost every tissue in the human body. It starts with the

mucosa, intestine, lungs and urinary system, and then progresses to the vascular system.[5]

The main targets of the virus are antigen-presenting cells, mainly dendritic cells and endothelial cells.[26][27][28] In 2012 it was reported how Lassa mammarenavirus nucleoprotein (NP) sabotages the host's

adaptive immunity. NP encoded in Lassa mammarenavirus is essential in viral replication and transcription, but it also suppresses host innate IFN response by inhibiting translocation of IRF-3. NP of Lassa mammarenavirus is reported to have an exonuclease activity to only dsRNAs.[29] the NP dsRNA exonuclease activity counteracts IFN responses by digesting the PAMPs thus allowing the virus to evade host immune responses.[30]

See also

References

  1. ^
    PMID 4246571
    .
  2. ^ "Lassa fever". www.who.int.
  3. S2CID 27063493
    .
  4. ^ .
  5. ^ .
  6. ^ "Lassa Fever | CDC". www.cdc.gov. Retrieved 2016-09-23.
  7. PMID 1614671
    .
  8. ^ .
  9. .
  10. .
  11. .
  12. .
  13. ^ .
  14. ^ Jamie Dyal and Ben Fohner Lassa virus Stanford University Humans and Viruses Class of 2005, n.d. accessed 9 May 2018
  15. ^ Lashley, Felissa R., and Jerry D. Durham. Emerging Infectious Diseases: Trends and Issues. New York: Springer Pub., 2002. Print.
  16. ^ Ridley, Matt. Genome: The Autobiography of a Species in 23 Chapters. New York: HarperCollins, 1999. Print.
  17. ^ "Lassa virus RefSeq Genome".
  18. PMID 11533204
    .
  19. .
  20. ^ .
  21. ^ Lashley F (2002). Emerging Infectious Diseases Trends and Issues. Springer Publishing Company.
  22. PMID 10888638
    .
  23. ^ "Endemic: MedlinePlus Medical Encyclopedia".
  24. ^
    PMID 18182084
    .
  25. ^ .
  26. .
  27. .
  28. .
  29. .
  30. .